Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Bernhard, Rintelen"'
Autor:
Dubravka Ukalovic, Burkhard F. Leeb, Bernhard Rintelen, Gabriela Eichbauer-Sturm, Peter Spellitz, Rudolf Puchner, Manfred Herold, Miriam Stetter, Vera Ferincz, Johannes Resch-Passini, Jochen Zwerina, Marcus Zimmermann-Rittereiser, Ruth Fritsch-Stork
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-12 (2024)
Abstract Objectives Machine learning models can support an individualized approach in the choice of bDMARDs. We developed prediction models for 5 different bDMARDs using machine learning methods based on patient data derived from the Austrian Biologi
Externí odkaz:
https://doaj.org/article/913cee245e814dc6866d24e0caf37144
Autor:
Erika Baum, Bernhard Rintelen, Heide Siggelkow, Klaus Engelke, Claus-C. Glüer, Friederike Thomasius
Publikováno v:
Osteologie. 32:92-96
Zusammenfassung Ziel Im Rahmen der Überarbeitung der 2017er Leitlinie Prophylaxe, Diagnostik und Therapie der Osteoporose bei postmenopausalen Frauen und bei Männern für den Deutschsprachigen Raum sollte das Risiko für osteoporosetypische Fraktur
Publikováno v:
International Journal of Rheumatology, Vol 2009 (2009)
Objectives. To compare the modified score for the assessment and quantification of chronic rheumatoid affections of the hands (M-SACRAH) with the Australian/Canadian osteoarthritis hand index (AUSCAN) in hand osteoarthritis (HOA). Both are self-admin
Externí odkaz:
https://doaj.org/article/d64266fb018d4f9d9d902cdde5c8c703
Autor:
Manfred Herold, P. Spellitz, Burkhard F. Leeb, G. Eichbauer-Sturm, Bernhard Rintelen, Rudolf Puchner, T. Nothnagl
Publikováno v:
Rheumatoid arthritis – prognosis, predictors and outcome.
Background The goal for the treatment of rheumatoid arthritis (RA) should be remission or at last low disease activity. Using data of the Austrian biologic registry we evaluated disease activity in patients with RA and treated with biologics for more
Autor:
Bernhard Rintelen
Publikováno v:
rheuma plus. 14:74-77
In diesem Beitrag werden praktische Tools fur Arzte und medizinisches Personal vorgestellt. Der sog. Osteo-Check erleichtert die Abklarung einer Osteoporose und hilft bei der Identifizierung von Risikofaktoren, die eine erhohte Knochenfragilitat zur
Autor:
Bernhard Rintelen, Manfred Herold, P. Spellitz, Burkhard F. Leeb, G. Eichbauer-Sturm, T. Nothnagl, Rudolf Puchner
Publikováno v:
Abstracts Accepted for Publication.
Background Remission or at last low disease activity is the aim of drug therapy in patients with chronic inflammatory rheumatic diseases. We evaluated disease activity in patients treated with biologics and using data of the Austrian biologic registr
Publikováno v:
Frontiers in Medicine
Objective The SF-SACRAH was developed to assess the involvement of the hand in rheumatoid arthritis (RA) and hand osteoarthritis (HOA) patients in daily clinical routines. In this pilot study, its sensitivity to change will be assessed longitudinally
Autor:
Judith Sautner, Harsono Mai, Pia M Haindl, Bernhard Rintelen, H.-P. Brezinschek, Burkhard F. Leeb
Publikováno v:
The Journal of Rheumatology. 40:394-400
Objective.We analyzed whether a patient self-report remission criterion, such as that according to the Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), meets the criteria of the 2011 proposed American College of Rheumatology/European League A
Publikováno v:
Clinical and experimental rheumatology. 34(5 Suppl 101)
Tighter monitoring of patients is regarded one of the key approaches to improve management of rheumatoid arthritis (RA). It could be demonstrated that the patient relevant disease course is not simply the linear link between two observation points, b
Autor:
Bernhard, Rintelen, Jochen, Zwerina, Manfred, Herold, Franz, Singer, Johann, Hitzelhammer, Wolfgang, Halder, Gabriela, Eichbauer-Sturm, Rudolf, Puchner, Miriam, Stetter, Burkhard F, Leeb, Jeanette, Wolf
Publikováno v:
BMC Musculoskeletal Disorders
Background The purpose of the present study was to check the validity of data collected in BIOREG, the Austrian register for biological treatment in rheumatology, and to elucidate eventual differences with respect to disease activity (DA) in patients